Proper knowledge on toxicokinetics improves human hazard testing and subsequent health risk characterisation. A case study approach.

In the current EU legislative frameworks on chemicals safety, the requirements with respect to information on general kinetic parameters (absorption, distribution, metabolism and excretion or ADME) or integrated toxicokinetic parameters (TK, i.e. plasma concentration-time curve, area under the curve etcetera) in humans and experimental animals vary widely. For agrochemicals and cosmetics, there are regulatory requirements whereas for other frameworks, such as food ingredients, biocides, consumer products and high production volume chemicals (REACH) there are very little or no requirements. This paper presents case studies that illustrate the importance of ADME and TK data in regulatory risk characterisations. The examples were collected by interviewing regulatory risk assessors from various chemicals (non-pharmaceutical) frameworks. The case studies illustrate how (1) applying ADME/TK in an early phase of toxicity testing can be used to improve study design and support the 3R-goals and how (2) increased use of ADME/TK data can improve the final risk assessment.

[1]  James S Bus,et al.  Strategies to assess systemic exposure of chemicals in subchronic/chronic diet and drinking water studies. , 2006, Toxicology and applied pharmacology.

[2]  Monique A J Rennen,et al.  Oral-to-inhalation route extrapolation in occupational health risk assessment: a critical assessment. , 2004, Regulatory toxicology and pharmacology : RTP.

[3]  Anika Ashok,et al.  ICH Harmonised Tripartite Guideline , 2009 .

[4]  Jacob Lekker,et al.  The placing of plant protection products on the market , 2014 .

[5]  A. Tritscher,et al.  Guidance on setting of acute reference dose (ARfD) for pesticides. , 2005, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[6]  Fernando Aguilar,et al.  Re‐evaluation of stannous chloride (E 512) as food additive , 2018, EFSA journal. European Food Safety Authority.

[7]  H. Buist,et al.  Relative absorption and dermal loading of chemical substances: Consequences for risk assessment. , 2009, Regulatory toxicology and pharmacology : RTP.

[8]  Kim Z Travis,et al.  Use of toxicokinetics to support chemical evaluation: Informing high dose selection and study interpretation. , 2012, Regulatory toxicology and pharmacology : RTP.

[9]  M. Rowland.  CLINICAL TRIALS AND TRANSLATIONAL MEDICINE COMMENTARIES Microdosing: A Critical Assessment of Human Data , 2012 .

[10]  Hugh A Barton,et al.  The Acquisition and Application of Absorption, Distribution, Metabolism, and Excretion (ADME) Data in Agricultural Chemical Safety Assessments , 2006, Critical reviews in toxicology.

[11]  J. Ploemen,et al.  The Use of Toxicokinetic Data in Preclinical Safety Assessment: A Toxicologic Pathologist Perspective , 2007, Toxicologic pathology.

[12]  Q. Chaudhry,et al.  Scientific Committee on Consumer Safety SCCS , 2010 .

[13]  J J van Hemmen,et al.  Toxicological risk assessment of worker exposure to pesticides: some general principles. , 1997, Regulatory toxicology and pharmacology : RTP.

[14]  Claire Terry,et al.  Assessment of diurnal systemic dose of agrochemicals in regulatory toxicity testing--an integrated approach without additional animal use. , 2012, Regulatory toxicology and pharmacology : RTP.

[15]  Malcolm Rowland,et al.  Microdosing: a critical assessment of human data. , 2012, Journal of pharmaceutical sciences.

[16]  Charles Timchalk,et al.  Comparative inter-species pharmacokinetics of phenoxyacetic acid herbicides and related organic acids. evidence that the dog is not a relevant species for evaluation of human health risk. , 2004, Toxicology.

[17]  D. Smith,et al.  Design of toxicokinetic studies. , 1990, Xenobiotica; the fate of foreign compounds in biological systems.